Mecamylamine Treatment for Alcohol Dependence: A Randomized Controlled Trial

BACKGROUND AND AIMS: The nicotinic acetylcholine receptor antagonist, mecamylamine, is a potential novel pharmacotherapy for alcohol use disorder. The aims were to compare alcohol consumption between mecamylamine and placebo and test if smoking status modified treatment effects. DESIGN: Outpatient,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Addiction
Autors principals: Petrakis, Ismene L., Ralevski, Elizabeth, Gueorguieva, Ralitza, O’Malley, Stephanie S., Arias, Albert, Sevarino, Kevin A., Jane, Jane S., O’Brien, Erin, Krystal, John H.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725262/
https://ncbi.nlm.nih.gov/pubmed/28710873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.13943
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars